＃68 🤖Virtual Influencers in B2B MedTech and Biotech: Building Algorithmic Trust Without Breaking Compliance Author: Kzone Chen / KYORYX Team Category: Marketing Strategy / Business Growth Listen to this article: Medical devices and biotech raw materials have long been treated as the least “social” corners of B2B. The buyer is a hospital procurement committee, a formulation scientist, or a quality lead. The sales cycle is measured in quarters. The language is academic. The regulatory envelope is unforgiving. For years, the default go-to-market system reflected that reality: face-to-face visits, flagship congresses, and dense technical white papers. That system is under structural strain. Travel and booth economics keep rising. Decision cycles keep stretching. Medical, legal, and regulatory review (MLR) is slower than the content calendar that marketing teams now try to run. Meanwhile, global B2B trade and supply chains are shifting toward always-on digital discovery, mul...
＃68 🤖Virtual Influencers in B2B MedTech and Biotech: Building Algorithmic Trust Without Breaking Compliance Author: Kzone Chen / KYORYX Team Category: Marketing Strategy / Business Growth Listen to this article: Medical devices and biotech raw materials have long been treated as the least “social” corners of B2B. The buyer is a hospital procurement committee, a formulation scientist, or a quality lead. The sales cycle is measured in quarters. The language is academic. The regulatory envelope is unforgiving. For years, the default go-to-market system reflected that reality: face-to-face visits, flagship congresses, and dense technical white papers. That system is under structural strain. Travel and booth economics keep rising. Decision cycles keep stretching. Medical, legal, and regulatory review (MLR) is slower than the content calendar that marketing teams now try to run. Meanwhile, global B2B trade and supply chains are shifting toward always-on digital discovery, mul...